老虎證券

美股詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Stealth Biotherapeutics Corp

0.3200
0.0000
成交量：- -
成交額：41.97萬
市值：2,353.68萬
市盈率：-0.35
高：0.3200
開：0.3200
低：0.3200
收：0.3200
52周最高：1.17
52周最低：0.1621
股本：7,355.25萬
流通股本：3,012.40萬
量比：- -
換手率：- -
股息：- -
股息率：- -
每股收益(TTM):-0.9237
每股收益(LYR):-0.9237
淨資產收益率：1027.89%
總資產收益率：-67.24%
市淨率：-0.52
市盈率(LYR):-0.35

資料載入中...

總覽公司新聞公告
2021/04/06

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/26

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/17

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/11/09

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/11/05

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/07/08

SEC問詢函

CORRESP [Cover] - Correspondence
2020/06/22

招股説明書

F-1 - Registration statement for certain foreign private issuers
2020/05/07

財報披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/16

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/04/13

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/08

SEC問詢函

CORRESP [Cover] - Correspondence
2020/04/03

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/02

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/04/01

年度報告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/16

非美公司披露報告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/09

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/01/07

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/31

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/12/20

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/14

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
更多